| Pharmaceutical active ingredients: |
| Methaqualone |
| Available forms, composition and doses of Mollinox: |
| N / A |
| Mollinox medical category: |
| Human:Central nervous system depressantsHypnotics and sedatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05CM01 - Methaqualone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Moilarorin | Furosemide | Unidentified Pharmaceutical Company |
| Molacco | Carbon Black | Unidentified Pharmaceutical Company |
| Moldamin | Benzathine Benzylpenicillin | Unidentified Pharmaceutical Company |
| Mole Death | Strychnine | Unidentified Pharmaceutical Company |
| Molinal | Phenobarbital | Unidentified Pharmaceutical Company |
| Molol | Mineral Oil | Unidentified Pharmaceutical Company |
| Molycor-R | Norfenefrine | Unidentified Pharmaceutical Company |
| Monacolin K | Lovastatin | Unidentified Pharmaceutical Company |
| Monafuracin | Nitrofurazone | Unidentified Pharmaceutical Company |
| Monafuracis | Nitrofurazone | Unidentified Pharmaceutical Company |